{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:40:38Z","timestamp":1787496038453,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s40261-019-00772-x","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T02:02:52Z","timestamp":1552874572000},"page":"411-418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Sufentanil 30\u00a0\u00b5g Sublingual Tablet: A Review in Acute Pain"],"prefix":"10.1007","volume":"39","author":[{"given":"Emma D.","family":"Deeks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"issue":"2","key":"772_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jpain.2015.12.008","volume":"17","author":"R Chou","year":"2016","unstructured":"Chou R, Gordon DB, de Leon-Casasola OA, et al. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists\u2019 Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016;17(2):131\u201357.","journal-title":"J Pain."},{"key":"772_CR2","doi-asserted-by":"crossref","unstructured":"Samcam I, Papa L. Acute pain management in the emergency department. In: Prostran M, editor. Pain management: IntechOpen; 2016.","DOI":"10.5772\/62861"},{"issue":"3","key":"772_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/204946371100500304","volume":"5","author":"L Keating","year":"2011","unstructured":"Keating L, Smith S. Acute pain in the emergency department: the challenges. Rev Pain. 2011;5(3):13\u20137.","journal-title":"Rev Pain."},{"key":"772_CR4","unstructured":"Pain Free Hospital. Guidelines for pain management in emergency & trauma department. \n                    http:\/\/www.moh.gov.my\n                    \n                  . Accessed 10 Jan 2019."},{"key":"772_CR5","unstructured":"Best Practice Advocacy Centre New Zealand. The principles of managing acute pain in primary care. 2018. \n                    https:\/\/bpac.org.nz\/2018\/acute-pain.aspx\n                    \n                  . Accessed 10 Jan 2019."},{"key":"772_CR6","unstructured":"World Health Organization. WHO\u2019s cancer pain ladder for adults. 2015. \n                    http:\/\/www.who.int\n                    \n                  . Accessed 10 Jan 2019."},{"issue":"5","key":"772_CR7","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1517\/17425247.2015.975202","volume":"12","author":"HS Minkowitz","year":"2015","unstructured":"Minkowitz HS, Candiotti K. The role of sublingual sufentanil nanotabs for pain relief. Expert Opin Drug Deliv. 2015;12(5):845\u201351.","journal-title":"Expert Opin Drug Deliv."},{"issue":"4","key":"772_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2217\/pmt.15.22","volume":"5","author":"HS Minkowitz","year":"2015","unstructured":"Minkowitz HS. A review of sufentanil and the sufentanil sublingual tablet system for acute moderate to severe pain. Pain Manag. 2015;5(4):237\u201350.","journal-title":"Pain Manag."},{"issue":"2","key":"772_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/14737175.2017.1260005","volume":"17","author":"S Porela-Tiihonen","year":"2017","unstructured":"Porela-Tiihonen S, Kokki M, Kokki H. Sufentanil sublingual formulation for the treatment of acute, moderate to severe postoperative pain in adult patients. Expert Rev Neurother. 2017;17(2):101\u201311.","journal-title":"Expert Rev Neurother"},{"issue":"6","key":"772_CR10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s40265-016-0571-6","volume":"76","author":"JE Frampton","year":"2016","unstructured":"Frampton JE. Sublingual sufentanil: a review in acute postoperative pain. Drugs. 2016;76(6):719\u201329.","journal-title":"Drugs."},{"key":"772_CR11","unstructured":"European Medicines Agency. Dzuveo: EU summary of product characteristics. 2018. \n                    https:\/\/www.ema.europa.eu\/\n                    \n                  . Accessed 25 Feb 2019."},{"key":"772_CR12","unstructured":"US Food and Drug Administration. Dsuvia (sufentanil sublingual tablet 30 mcg): US prescribing information. 2018. \n                    https:\/\/www.accessdata.fda.gov\/\n                    \n                  . Accessed 25 Feb 2019."},{"issue":"11","key":"772_CR13","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/j.1440-1681.1995.tb01945.x","volume":"22","author":"LE Mather","year":"1995","unstructured":"Mather LE. Opioids - a pharmacologist\u2019s delight! Clin Exp Pharmacol Physiol. 1995;22(11):833\u20136.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"5","key":"772_CR14","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1016\/j.jpainsymman.2005.01.012","volume":"29","author":"JR Lotsch","year":"2005","unstructured":"Lotsch JR. Pharmacokinetic-pharmacodynamic modeling of opioids. J Pain Symptom Manag. 2005;29(5):S90\u2013103.","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"772_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.clinthera.2014.11.001","volume":"37","author":"SK Willsie","year":"2015","unstructured":"Willsie SK, Evashenk MA, Hamel LG, et al. Pharmacokinetic properties of single- and repeated-dose sufentanil sublingual tablets in healthy volunteers. Clin Ther. 2015;37(1):145\u201355.","journal-title":"Clin Ther"},{"key":"772_CR16","unstructured":"Didonato K, Palmer P. Pharmacokinetics of a single dose of sufentanil sublingual tablet 30 mcg vs intravenous sufenta\u00ae 30 mcg (50 mcg\/ml) infused over 1 minute in healthy volunteers [abstract no. 142]. Pain Med. 2017;18(3):585."},{"issue":"5","key":"772_CR17","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1097\/ALN.0000000000002145","volume":"128","author":"DM Fisher","year":"2018","unstructured":"Fisher DM, Chang P, Wada DR, et al. Pharmacokinetic properties of a sufentanil sublingual tablet intended to treat acute pain. Anesthesiology. 2018;128(5):943\u201352.","journal-title":"Anesthesiology"},{"issue":"7","key":"772_CR18","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/papr.12531","volume":"17","author":"HS Minkowitz","year":"2017","unstructured":"Minkowitz HS, Leiman D, Melson T, et al. Sufentanil sublingual tablet 30 mcg for the management of pain following abdominal surgery: a randomized, placebo-controlled, phase-3 study. Pain Pract. 2017;17(7):848\u201358.","journal-title":"Pain Pract."},{"issue":"3","key":"772_CR19","doi-asserted-by":"publisher","first-page":"S198","DOI":"10.1097\/TA.0000000000000373","volume":"77","author":"NK Singla","year":"2014","unstructured":"Singla NK, Muse DD, Evashenk MA, et al. A dose-finding study of sufentanil sublingual microtablets for the management of postoperative bunionectomy pain. J Trauma Acute Care Surg. 2014;77(3):S198\u2013203.","journal-title":"J Trauma Acute Care Surg."},{"issue":"6","key":"772_CR20","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.ajem.2017.10.058","volume":"36","author":"JR Miner","year":"2018","unstructured":"Miner JR, Rafique Z, Minkowitz HS, et al. Sufentanil sublingual tablet 30 mcg for moderate-to-severe acute pain in the ED. Am J Emerg Med. 2018;36(6):954\u201361.","journal-title":"Am J Emerg Med"},{"issue":"10","key":"772_CR21","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1093\/pm\/pnx248","volume":"19","author":"JL Hutchins","year":"2018","unstructured":"Hutchins JL, Leiman D, Minkowitz HS, et al. An open-label study of sufentanil sublingual tablet 30 mcg in patients with postoperative pain. Pain Med. 2018;19(10):2058\u201368.","journal-title":"Pain Med."},{"key":"772_CR22","unstructured":"Minkowitz H, Melson T, Leiman D, et al. Comprehensive efficacy and integrated safety results from the late-phase clinical program of the Sufentanil sublingual tablet 30 mcg [poster]. In: 42nd Annual Regional Anesthesiology and Acute Pain Medicine Meeting. 2017"},{"key":"772_CR23","doi-asserted-by":"publisher","unstructured":"Miner JR, Melson TI, Leiman D, et al. Pooled phase III safety analysis of sufentanil sublingual tablets for short-term treatment of moderate-to-severe acute pain. Pain Manag. 2019. \n                    https:\/\/doi.org\/10.2217\/pmt-2018-0090\n                    \n                  .","DOI":"10.2217\/pmt-2018-0090"},{"key":"772_CR24","unstructured":"Faculty of Pain Medicine. Opioids and acute pain management. 2019. \n                    https:\/\/www.rcoa.ac.uk\/faculty-of-pain-medicine\/\n                    \n                  . Accessed 10 Jan 2019."},{"key":"772_CR25","unstructured":"The College of Emergency Medicine. Best practice guideline. Management of pain in adults. 2014. \n                    https:\/\/www.rcem.ac.uk\n                    \n                  . Accessed 10 Jan 2019."},{"key":"772_CR26","unstructured":"Malek J, Sevcik P, et al. Postoperative pain management. 2017. \n                    https:\/\/www.wfsahq.org\/components\/com_virtual_library\/media\/125136f77e1b7daf7565bd6653026c35-Postoperative-Pain-Management-170518.pdf\n                    \n                  . Accessed 10 Jan 2019."},{"issue":"13","key":"772_CR27","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMra1507771","volume":"374","author":"ND Volkow","year":"2016","unstructured":"Volkow ND, McLellan AT. Opioid abuse in chronic pain\u2014misconceptions and mitigation strategies. N Engl J Med. 2016;374(13):1253\u201363.","journal-title":"N Engl J Med"},{"key":"772_CR28","doi-asserted-by":"crossref","unstructured":"Krans B. Should FDA have approved \u2018super opioid\u2019 that\u2019s stronger than fentanyl? 2018. \n                    https:\/\/www.healthline.com\/\n                    \n                  . Accessed 10 Jan 2019.","DOI":"10.1093\/oso\/9780198806837.003.0004"},{"key":"772_CR29","unstructured":"Hlavinka E. AcelRx pushes safety analysis on powerful new opioid\u2014but bulk of data uses unapproved sufentanil dosing [media release]. 8 Jan 2019. \n                    https:\/\/www.medpagetoday.com\/painmanagement\/painmanagement\/77323\n                    \n                  ."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-019-00772-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-019-00772-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-019-00772-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T20:12:45Z","timestamp":1584389565000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-019-00772-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1007\/s40261-019-00772-x","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]},"assertion":[{"value":"18 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The preparation of this review was not supported by any external funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Emma Deeks is a salaried employee of Adis\/Springer, is responsible for the article content and declares no relevant conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}